Refine Search

Search Results

5 results found.

Don’t Miss Out
by Catherine LeGraw of GMO, 10/30/24

Deep value stocks are GMO Asset Allocation’s highest conviction investment idea. In a world where many stocks are being driven ever higher by positive sentiment and investor optimism, some fundamentally sound but unloved companies are being left behind, consequently trading at extraordinary discounts.

It's Always Darkest Before the Dawn
by Ben Inker, Catherine LeGraw, John Pease, John Thorndike of GMO, 4/9/20

In a new white paper from GMO’s Asset Allocation team -- "It's Always Darkest Before the Dawn" -- Ben Inker, Catherine LeGraw, John Pease and John Thorndike examine the three phases of bear markets against the backdrop of the current market environment.

7-Year Asset Class Forecasts Increase After Steep Market Declines
by Catherine LeGraw of GMO, 1/16/19

Steep declines across most asset classes in the second half of 2018 resulted in significant increases in forward-looking returns.

The Case for Not Currency Hedging Foreign Equity Investments: A U.S. Investor’s Perspective
by Catherine LeGraw of GMO, 4/14/15
In a new white paper, Catherine LeGraw of GMO's asset allocation team explains GMO's approach to currency hedging, a topic which has gained relevance as the U.S. dollar has strengthened.

De-risking Goes Beyond Interest Rate Risk: The Case for Dynamic Asset Allocation in an LDI Solution
by Catherine LeGraw of GMO, 3/19/15
In this piece, we introduce a measure of valuation risk, and demonstrate how rotating growth assets into a valuation-aware dynamic strategy can help to reduce risk, improve long-term returns, and help improve funded status in the case of a reversion to the mean.
5 results found.